News › Industry News, News

Novo Nordisk Finds Compounded Wegovy up to 33% Impure, Sues Florida Pharmacies

December 19, 2023
Lady justice and her scale

Novo Nordisk said it sued one compounding pharmacy and refiled a lawsuit against another after finding their products claiming to contain the active ingredient for its in-demand weight-loss drug Wegovy were impure, some by as much as 33%.

The Danish drugmaker said it found impurities in all the drugs tested from Wells Pharmacy and Brooksville Pharmaceuticals, both based in Florida. Novo first sued Brooksville in July, and discovered a substance called BPC-157 in samples from Wells.

Read more at Reuters >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • SafeLink Consulting Inc. Launches SafeLink360, Bringing Risk & Compliance Management and Expert Support Together in One Platform
    • TITAN Aesthetic Founder Mary Beth Hagen Transfers Ownership to Carrie Galpin
    • AmSpa’s Medical Spa Show Voted Best Tradeshow Injectable Education
    • Ohio Med Spa Fined $25,000 Following Prescription Drug Violations Investigation
    • Mississippi Boards Warn Against Use of ‘Research-Grade’ Peptides
Advertisement